2021
The Value of Assessing Self-Reported and Biological Indicators of Outcomes in Evaluating HIV Programs
Zimmerman R, Mehrotra P, Madden T, Paul R. The Value of Assessing Self-Reported and Biological Indicators of Outcomes in Evaluating HIV Programs. Current HIV/AIDS Reports 2021, 18: 365-376. PMID: 33993397, DOI: 10.1007/s11904-021-00560-3.Peer-Reviewed Original ResearchMeSH KeywordsCondomsEnvironmental BiomarkersHIV InfectionsHumansPre-Exposure ProphylaxisSafe SexSelf ReportConceptsAntiretroviral medicationsCondom useLow-resource settingsUnprotected sexHIV statusHIV programsHigh-income countriesPre-exposure prophylaxis medicationsBlood spotsRapid HIV testsHIV-positive statusIncorrect condom useStigma of HIVRecent FindingsRecent studiesPurpose of ReviewInLow-income settingsProphylaxis medicationsHIV testBiological measuresStandardized self-report measuresPositive statusCondom usageLow-income countriesRapid testBiomarkers
2020
Decisional conflict associated with clinicians discouraging particular contraceptive methods
Grant R, Paul R, Zeal C, Madden T, Politi M. Decisional conflict associated with clinicians discouraging particular contraceptive methods. Journal Of Evaluation In Clinical Practice 2020, 26: 1612-1619. PMID: 32026566, DOI: 10.1111/jep.13364.Peer-Reviewed Original ResearchConceptsParticular contraceptive methodsContraceptive methodsSelf-reported outcomesDecisional conflictSide effectsPrimary self-reported outcomesSecondary self-report outcomesProportion of participantsYears of ageSelf-reported qualityContraceptive method selectionUse of contraceptionFemale sexPatient preferencesUnintended pregnancyEligible individualsClinicians' reasonsContraceptive attributesContraceptive featuresCliniciansContraceptive decisionsAnonymous surveyNulliparityPregnancyContraception